Citation 80278

BECKER,U: ERKEL,G: KOCKSCH,G: ANKE,T: STERNER,O:. (1997). PULVINATAL, A NOVEL BIOACTIVE METABOLITE FROM THE BASIDIOMYCETE NIDULARIA PULVINATA 9SCHW.) FR.. 52(5/6)

Citation Details

TitlePULVINATAL, A NOVEL BIOACTIVE METABOLITE FROM THE BASIDIOMYCETE NIDULARIA PULVINATA 9SCHW.) FR.
AuthorsBECKER,U: ERKEL,G: KOCKSCH,G: ANKE,T: STERNER,O:
Year1997
Volume52
Issue5/6

Summary

Year: 1997

Journal: Unknown

Organisms and Their Experiments (1)

Nidularia pulvinata (NIDULARIALES)

Experiment #Pharmacology TypeWorktypesCompoundResults
1Not specified
VOUCHER SPECIMEN REPORTED FORUV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
PULVINATAL
None
2
ANTIYEAST ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
PULVINATAL
ACTIVE
3
ANTIYEAST ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
PULVINATAL
ACTIVE
4
ANTIFUNGAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
PULVINATAL
ACTIVE
5
MUTAGENIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
PULVINATAL
ACTIVE
6
MUTAGENIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
PULVINATAL
ACTIVE
7
PARANITROANISOLE-O-DEMETHYLASE INDUCTION
PHARMACOLOGY OF COMPOUND - IN VITRO
PULVINATAL
ACTIVE
8
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PULVINATAL
INACTIVE
9
CELL DIFFERENTIATION INDUCTION
PHARMACOLOGY OF COMPOUND - IN VITRO
PULVINATAL
WEAK ACTIVITY
10
RNA SYNTHESIS INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
PULVINATAL
WEAK ACTIVITY
11
DNA SYNTHESIS INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
PULVINATAL
WEAK ACTIVITY
12
PROTEIN SYNTHESIS INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
PULVINATAL
WEAK ACTIVITY
13Not specified
ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA
ORSELLINIC ACID
None
14
MUTAGENIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
ORSELLINIC ACID
ACTIVE
15
MUTAGENIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
ORSELLINIC ACID
ACTIVE
16Not specified
ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATA
BENZENE-CARBALDEHYDE,2-4-5-TRIHYDROXY-6-METHYL:
None
17
CELL DIFFERENTIATION INDUCTION
PHARMACOLOGY OF COMPOUND - IN VITRO
BENZENE-CARBALDEHYDE,2-4-5-TRIHYDROXY-6-METHYL:
ACTIVE
18
CELL DIFFERENTIATION INDUCTION
PHARMACOLOGY OF COMPOUND - IN VITRO
BENZENE-CARBALDEHYDE,2-4-5-TRIHYDROXY-6-METHYL:
INACTIVE
19
MUTAGENIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
BENZENE-CARBALDEHYDE,2-4-5-TRIHYDROXY-6-METHYL:
ACTIVE
20
MUTAGENIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
BENZENE-CARBALDEHYDE,2-4-5-TRIHYDROXY-6-METHYL:
ACTIVE
21
RNA SYNTHESIS INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
BENZENE-CARBALDEHYDE,2-4-5-TRIHYDROXY-6-METHYL:
WEAK ACTIVITY
22
DNA SYNTHESIS INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
BENZENE-CARBALDEHYDE,2-4-5-TRIHYDROXY-6-METHYL:
WEAK ACTIVITY
23
PROTEIN SYNTHESIS INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
BENZENE-CARBALDEHYDE,2-4-5-TRIHYDROXY-6-METHYL:
WEAK ACTIVITY
Show SPARQL Queries (1)